⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CMPS News
COMPASS Pathways Plc American Depository Shares
Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
businesswire.com
CMPS
Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials
businesswire.com
CMPS
Comply Expands Regulatory Expertise to Deliver End-to-End Compliance from a Single Trusted Partner
globenewswire.com
CMPS
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
businesswire.com
CMPS
Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360
businesswire.com
CMPS
Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (TRD) and Clinical Trial Plans for Post-Traumatic Stress Disorder (PTSD) on January 7, 2026, 10:00am ET
businesswire.com
CMPS
IMS25 versammelt globale Vordenker in Riad: Rekordbeteiligung und wichtige Ankündigungen prägen die Zukunft der MICE-Branche USA - Deutsch USA - English Middle East - English BRAZIL - Portuguese MEXICO - Spanish
prnewswire.com
MCH
OAKVF
CMPS
HONEF
RXRX
IFX
MCK
CLAR
GL
DMGE
Compass Pathways to Participate in Two Investor Conferences in December
businesswire.com
CMPS
Compass Pathways to Participate in Stifel 2025 Healthcare Conference
businesswire.com
CMPS
Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months
businesswire.com
CMPS